enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Astellas Pharma - Wikipedia

   en.wikipedia.org/wiki/Astellas_Pharma

   Astellas Pharma office in Canada. Astellas Pharma Inc. (アステラス製薬株式会社, Asuterasu Seiyaku Kabushiki-gaisha) is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. (山之内製薬株式会社, Yamanouchi Seiyaku Kabushiki-gaisha) and Fujisawa Pharmaceutical Co., Ltd. (藤沢薬品工業株式会社 ...

3. List of largest biomedical companies by revenue - Wikipedia

   en.wikipedia.org/wiki/List_of_largest_biomedical...

   The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.

4. US FDA declines to approve Astellas' gastric cancer drug - AOL

   www.aol.com/news/us-fda-declines-approve...

   (Reuters) - Japan's Astellas Pharma said on Monday the U.S. Food and Drug Administration (FDA) has declined to approve its experimental drug to treat a type of gastric cancer, citing issues ...

5. Astellas withdraws lawsuit challenging Medicare drug price ...

   www.aol.com/news/astellas-withdraws-lawsuit...

   Several analysts had expected Astellas' prostate cancer drug to be part of the list. The U.S. government, late last month, selected the first 10 drugs, including the top-selling blood thinner ...

6. Astellas Pharma Invests $50M To Support Taysha's Gene ... - AOL

   www.aol.com/news/astellas-pharma-invests-50m...

   Japan-based Astellas Pharma Inc (OTC: ALPMF) (OTC: ALPMY) announced a strategic investment to support the advancement of Taysha Gene Therapies Inc's (NASDAQ: TSHA) adeno-associated virus (AAV ...

7. Ipragliflozin - Wikipedia

   en.wikipedia.org/wiki/Ipragliflozin

   Ipragliflozin (INN, [2]: 69 trade names Suglat) is a pharmaceutical drug for treatment of type 2 diabetes. Ipragliflozin, jointly developed by Astellas Pharma and Kotobuki Pharmaceutical, was approved in Japan on January 17, 2014, [3] and in Russia on May 22, 2019. [4] Ipragliflozin is a Sodium/glucose cotransporter 2 (SGLT2) inhibitor . [5]

8. Japan's Astellas Goes Hostile on OSI Pharma With a $3.5 ... - AOL

   www.aol.com/news/2010-03-01-japans-astellas-goes...

   Astellas Pharma, Japan's No. 2 drugmaker, has wanted to get a footprint in the U.S. market. And this means making an acquisition. So, Astellas has spent 13 months trying to purchase OSI ...

9. Category:Astellas Pharma - Wikipedia

   en.wikipedia.org/wiki/Category:Astellas_Pharma

   Astellas Pharma, a multinational pharmaceutical company of Japan, and part of the Mitsubishi UFJ Financial Group conglomerate. Pages in category "Astellas Pharma" The following 27 pages are in this category, out of 27 total.